Literature DB >> 36247305

Cytokines associated with immune response in atherosclerosis.

Jiqing Ma1, Jianhua Luo2, Yudong Sun3, Zhiqing Zhao1.   

Abstract

Inflammation is an essential mechanism of immune response that involves a large number of different immune cells. Atherosclerosis is essentially an inflammatory disease caused by inappropriate activities of immune cells. During this process, various cytokines activate immune cells, regulate and transmit immune cell signals, and stimulate a local inflammatory environment. In this study, we reviewed the cytokines associated with immune activity in atherosclerosis, including their roles in immune cell activation and mediating immune cell chemotaxis. The findings give important insights into inflammatory immune microenvironment, including basic mechanisms and interactions, providing new ideas and options for clinical detection and treatment of this disease. AJTR
Copyright © 2022.

Entities:  

Keywords:  Atherosclerosis; cytokine; immunity

Year:  2022        PMID: 36247305      PMCID: PMC9556506     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  146 in total

1.  Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response.

Authors:  Robert A Mitchell; Hong Liao; Jason Chesney; Gunter Fingerle-Rowson; John Baugh; John David; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

Review 2.  Anticytokine autoantibody-associated immunodeficiency.

Authors:  Sarah K Browne
Journal:  Annu Rev Immunol       Date:  2014-02-05       Impact factor: 28.527

Review 3.  The regulation and importance of monocyte chemoattractant protein-1.

Authors:  Vanessa Bianconi; Amirhossein Sahebkar; Stephen L Atkin; Matteo Pirro
Journal:  Curr Opin Hematol       Date:  2018-01       Impact factor: 3.284

4.  Interferon-γ-mediated allograft rejection exacerbates cardiovascular disease of hyperlipidemic murine transplant recipients.

Authors:  Jing Zhou; Lingfeng Qin; Tai Yi; Rahmat Ali; Qingle Li; Yang Jiao; Guangxin Li; Zuzana Tobiasova; Yan Huang; Jiasheng Zhang; James J Yun; Mehran M Sadeghi; Frank J Giordano; Jordan S Pober; George Tellides
Journal:  Circ Res       Date:  2015-09-23       Impact factor: 17.367

5.  Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters.

Authors:  Stephanie Pitsilos; Jennifer Hunt; Emile R Mohler; Anand M Prabhakar; Mortimer Poncz; Jennine Dawicki; Tigran Z Khalapyan; Megan L Wolfe; Ronald Fairman; Marc Mitchell; Jeffrey Carpenter; Michael A Golden; Douglas B Cines; Bruce S Sachais
Journal:  Thromb Haemost       Date:  2003-12       Impact factor: 5.249

Review 6.  Interferon gamma: a master regulator of atherosclerosis.

Authors:  James E McLaren; Dipak P Ramji
Journal:  Cytokine Growth Factor Rev       Date:  2008-11-28       Impact factor: 7.638

7.  Soluble CXCL16 and risk of myocardial infarction: The HUNT study in Norway.

Authors:  Lars E Laugsand; Bjørn O Åsvold; Lars J Vatten; Imre Janszky; Carl Platou; Annika E Michelsen; Fizza Arain; Jan K Damås; Pål Aukrust; Thor Ueland
Journal:  Atherosclerosis       Date:  2015-11-25       Impact factor: 5.162

8.  CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival.

Authors:  Limor Landsman; Liat Bar-On; Alma Zernecke; Ki-Wook Kim; Rita Krauthgamer; Erdenechimeg Shagdarsuren; Sergio A Lira; Irving L Weissman; Christian Weber; Steffen Jung
Journal:  Blood       Date:  2008-10-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.